If you need more lookups,
subscriptions start at $34 USD/month.
Ting Liu Location
Switzerland
Ting Liu Work
Principal Medical Director @ (April 2025 - Present)
Senior Medical Director, Safety Strategy Leader @ (November 2021 - March 2025)
Clinical Team Leader and MD, Early Development Oncology @ (April 2023 - June 2024)
Toxicologist in Pharma Research and Early Development (part-time rotation) @ (April 2022 - March 2023)
Medical Director, Safety Science Leader @ (January 2019 - October 2021)
Clinical Scientist Oncology @ (August 2014 - January 2019)
Regulatory Affairs Manager and Specialist @ (March 2013 - August 2014)
Healthcare consultant trainee and Medical specialist @ Strategic Access Solutions Ltd - Stratas Partners (January 2012 - January 2013)
Regulatory Affairs Specialist @ (January 2010 - January 2011)
Postdoctoral Fellow @ (January 2009 - January 2010)
Resident Physician @ Affiliated Tangshan Gongren Hospital, Hebei Medical University (January 1998 - January 1999)
Ting Liu Education
University of Basel
Diploma of Advanced Studies in Pharmaceutical Medicine
2019-2021
University of Basel
Doctor of Philosophy (Ph.D.) (Biological Medicine)
2005-2009
Peking Union Medical College
Master of Medicine
1999-2002
Ting Liu Skills
Clinical Development
Clinical Research
Clinical Trials
Drug Development
Gene Therapy
Life Cycle Management
Life Sciences
Lifesciences
Medical Education
Medical Writing
Molecular Biology
Oncology
Patient Safety
Pharmaceutics
Product Lifecycle Management
Radiopharmaceuticals
Regulatory Affairs
Regulatory Submissions
Ting Liu Summary
Ting Liu, based in Switzerland, is currently a Principal Medical Director at Roche. Ting Liu brings experience from previous roles at Roche. Ting Liu holds a 2019 - 2021 Diploma of Advanced Studies in Pharmaceutical Medicine @ University of Basel. With a robust skill set that includes Clinical Development, Clinical Research, Clinical Trials, Drug Development, Gene Therapy and more. Ting Liu has 2 emails on RocketReach.
Looking for a different Ting Liu?
Find contact details for 700 million professionals.